Literature DB >> 19914561

Randomized clinical trials in gastric cancer.

James J Mezhir1, Venu G Pillarisetty, Manish A Shah, Daniel G Coit.   

Abstract

Minimally invasive resection has emerged as a surgical technique for gastric cancer, and there has been continued investigation to determine the appropriate extent of lymphadenectomy in gastric cancer patients. There has also been significant progress in evaluating the role of chemotherapeutic regimens used in the neoadjuvant and adjuvant settings for patients with resectable disease. We also summarize a selection of RCT trials focused on the perioperative care of the gastric cancer patient.

Entities:  

Mesh:

Year:  2010        PMID: 19914561     DOI: 10.1016/j.soc.2009.09.011

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

1.  Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?

Authors:  Vikas Dudeja; Elizabeth B Habermann; Anasooya Abraham; Wei Zhong; Helen M Parsons; Jennifer F Tseng; Waddah B Al-Refaie
Journal:  J Gastrointest Surg       Date:  2011-11-17       Impact factor: 3.452

Review 2.  Measurement and interpretation of patient-reported outcomes in surgery: an opportunity for improvement.

Authors:  Paul J Karanicolas; Kai Bickenbach; Shiva Jayaraman; Andrea L Pusic; Daniel G Coit; Gordon H Guyatt; Murray F Brennan
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

3.  Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2.

Authors:  Zitong Wang; Yingying Chen; Xiaoyu Li; Yuhan Zhang; Xiaokun Zhao; Hao Zhou; Xuebo Lu; Lili Zhao; Qiang Yuan; Yunshu Shi; Jimin Zhao; Ziming Dong; Yanan Jiang; Kangdong Liu
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.